Transmitter release at the mouse neuromuscular junction stimulated by cadmium ions. 1984

M Nishimura, and I Tsutsui, and O Yagasaki, and I Yanagiya

Cadmium ion (Cd2+) was examined for effects on frequency of miniature end-plate potentials (m.e.p.p.s) under several conditions in mouse diaphragm muscles. Cd2+ depressed potassium (K+)-stimulated rise in m.e.p.p. frequency, acting antagonistically to Ca2+, whereas in the absence of K+ stimulation Cd2+ produced a time- and concentration-dependent rise in m.e.p.p. frequency without affecting the resting membrane potential of muscle fibers. Such a presynaptic effect was observed with or without external Ca2+ [( Ca]0). In the absence of [Ca]0, Cd2+ frequently produced twitching in several fibers, which caused dislodgement of the micro-electrode. Therefore, 10 mM KCl was added to the Ca-free solution to overcome such difficulty. The following experiments were performed in the Ca-free 10 mM KCl solution. Prolonged exposure to Cd2+ led to an eventual decline in m.e.p.p. frequency within 20-30 min. After decline of the effect, m.e.p.p. frequency in the presence of Cd2+ was not restored by adding Ca2+ combined with elevated K+ and with A23187 or by carbonyl cyanide p-trifluoromethoxyphenyl hydrazine and hypoxic condition, each of which was separately effective in enhancing transmitter release. Exposure to 50 microM Cd2+ for 60 min decreased acetylcholine content in diaphragm muscle to approximately 50% of control. Tetrodotoxin and caffeine did not modify the presynaptic stimulatory effect of Cd2+. The effect of Cd2+ on m.e.p.p. frequency was partially reduced by trifluoperazine and phenytoin each of which depressed m.e.p.p. frequency rise induced by Ca2+ with elevated K+. The possible mechanism of Cd2+ action and of its interaction with intracellular Ca2+ stores is discussed.

UI MeSH Term Description Entries
D008564 Membrane Potentials The voltage differences across a membrane. For cellular membranes they are computed by subtracting the voltage measured outside the membrane from the voltage measured inside the membrane. They result from differences of inside versus outside concentration of potassium, sodium, chloride, and other ions across cells' or ORGANELLES membranes. For excitable cells, the resting membrane potentials range between -30 and -100 millivolts. Physical, chemical, or electrical stimuli can make a membrane potential more negative (hyperpolarization), or less negative (depolarization). Resting Potentials,Transmembrane Potentials,Delta Psi,Resting Membrane Potential,Transmembrane Electrical Potential Difference,Transmembrane Potential Difference,Difference, Transmembrane Potential,Differences, Transmembrane Potential,Membrane Potential,Membrane Potential, Resting,Membrane Potentials, Resting,Potential Difference, Transmembrane,Potential Differences, Transmembrane,Potential, Membrane,Potential, Resting,Potential, Transmembrane,Potentials, Membrane,Potentials, Resting,Potentials, Transmembrane,Resting Membrane Potentials,Resting Potential,Transmembrane Potential,Transmembrane Potential Differences
D008931 Mitochondria, Muscle Mitochondria of skeletal and smooth muscle. It does not include myocardial mitochondria for which MITOCHONDRIA, HEART is available. Sarcosomes,Mitochondrion, Muscle,Muscle Mitochondria,Muscle Mitochondrion,Sarcosome
D009045 Motor Endplate The specialized postsynaptic region of a muscle cell. The motor endplate is immediately across the synaptic cleft from the presynaptic axon terminal. Among its anatomical specializations are junctional folds which harbor a high density of cholinergic receptors. Motor End-Plate,End-Plate, Motor,End-Plates, Motor,Endplate, Motor,Endplates, Motor,Motor End Plate,Motor End-Plates,Motor Endplates
D009469 Neuromuscular Junction The synapse between a neuron and a muscle. Myoneural Junction,Nerve-Muscle Preparation,Junction, Myoneural,Junction, Neuromuscular,Junctions, Myoneural,Junctions, Neuromuscular,Myoneural Junctions,Nerve Muscle Preparation,Nerve-Muscle Preparations,Neuromuscular Junctions,Preparation, Nerve-Muscle,Preparations, Nerve-Muscle
D002104 Cadmium An element with atomic symbol Cd, atomic number 48, and atomic weight 112.41. It is a metal and ingestion will lead to CADMIUM POISONING.
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D003964 Diaphragm The musculofibrous partition that separates the THORACIC CAVITY from the ABDOMINAL CAVITY. Contraction of the diaphragm increases the volume of the thoracic cavity aiding INHALATION. Respiratory Diaphragm,Diaphragm, Respiratory,Diaphragms,Diaphragms, Respiratory,Respiratory Diaphragms
D000001 Calcimycin An ionophorous, polyether antibiotic from Streptomyces chartreusensis. It binds and transports CALCIUM and other divalent cations across membranes and uncouples oxidative phosphorylation while inhibiting ATPase of rat liver mitochondria. The substance is used mostly as a biochemical tool to study the role of divalent cations in various biological systems. 4-Benzoxazolecarboxylic acid, 5-(methylamino)-2-((3,9,11-trimethyl-8-(1-methyl-2-oxo-2-(1H-pyrrol-2-yl)ethyl)-1,7-dioxaspiro(5.5)undec-2-yl)methyl)-, (6S-(6alpha(2S*,3S*),8beta(R*),9beta,11alpha))-,A-23187,A23187,Antibiotic A23187,A 23187,A23187, Antibiotic
D000109 Acetylcholine A neurotransmitter found at neuromuscular junctions, autonomic ganglia, parasympathetic effector junctions, a subset of sympathetic effector junctions, and at many sites in the central nervous system. 2-(Acetyloxy)-N,N,N-trimethylethanaminium,Acetilcolina Cusi,Acetylcholine Bromide,Acetylcholine Chloride,Acetylcholine Fluoride,Acetylcholine Hydroxide,Acetylcholine Iodide,Acetylcholine L-Tartrate,Acetylcholine Perchlorate,Acetylcholine Picrate,Acetylcholine Picrate (1:1),Acetylcholine Sulfate (1:1),Bromoacetylcholine,Chloroacetylcholine,Miochol,Acetylcholine L Tartrate,Bromide, Acetylcholine,Cusi, Acetilcolina,Fluoride, Acetylcholine,Hydroxide, Acetylcholine,Iodide, Acetylcholine,L-Tartrate, Acetylcholine,Perchlorate, Acetylcholine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

M Nishimura, and I Tsutsui, and O Yagasaki, and I Yanagiya
October 1987, Canadian journal of physiology and pharmacology,
M Nishimura, and I Tsutsui, and O Yagasaki, and I Yanagiya
April 1984, European journal of pharmacology,
M Nishimura, and I Tsutsui, and O Yagasaki, and I Yanagiya
January 2006, International review of neurobiology,
M Nishimura, and I Tsutsui, and O Yagasaki, and I Yanagiya
August 1988, Puerto Rico health sciences journal,
M Nishimura, and I Tsutsui, and O Yagasaki, and I Yanagiya
July 1971, The Journal of physiology,
M Nishimura, and I Tsutsui, and O Yagasaki, and I Yanagiya
January 1990, Pharmacological research,
M Nishimura, and I Tsutsui, and O Yagasaki, and I Yanagiya
August 1980, Chemico-biological interactions,
M Nishimura, and I Tsutsui, and O Yagasaki, and I Yanagiya
March 1975, The Journal of physiology,
M Nishimura, and I Tsutsui, and O Yagasaki, and I Yanagiya
September 1991, British journal of pharmacology,
M Nishimura, and I Tsutsui, and O Yagasaki, and I Yanagiya
January 1988, Fundamental & clinical pharmacology,
Copied contents to your clipboard!